好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Family Composition and Family Care Priorities at an Academic Memory Disorders Clinic
Aging and Dementia
P07 - (-)
143
BACKGROUND: Dementia care is most often delivered in family settings. Understanding the make-up of families seeking care and how they view their care needs may improve the effectiveness of dementia treatment and promote patient satisfaction.
DESIGN/METHODS: Eighty-one caregiver/patient dyads seeking care at an academic dementia clinic reported what relationships they considered "family" with reference to dementia care and completed 7-item questionnaires that addressed (1) family interactions, (2) activities of daily living, (3) mood and emotion, (4) physical well-being, (5) cognition, (6) information related to care provision, and (7) ways to improve family function. Questionnaire responses were classified as being focused primarily on (1) an individual's needs, (2) the family's needs, or (3) neither.
RESULTS: Seventy-seven dyads provided evaluable data. Mean age of patients was 72.1 years and 53% were male. Mean age of caregivers was 62.1 and 72% were female. Patients identified an average of 3.77 family members which often included their spouse (80.5%), daughter (58.4%), son (46.8%), step-sibling or in-law (37.7%). All caregiver/patient dyads provided at least two responses identifying family needs. Questions regarding changes in cognition or mood, and their effect on family interactions were most likely to elicit a response referring to family needs. Questions regarding care provision and improving family function were more likely to trigger responses regarding an individual's needs.
CONCLUSIONS: Families caring for people with dementia often extend beyond spousal or individual parent-child relationships. Both caregivers and persons with dementia frequently provided responses regarding the family's needs and the impact of dementia on family life. This reinforces the importance of addressing the needs of the caregiving family in dementia treatment.
Authors/Disclosures
David Geldmacher, MD (UAB Department of Neurology)
PRESENTER 		Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Geldmacher has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BrownGreer. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Premier, Inc. Dr. Geldmacher has stock in Doximity. The institution of Dr. Geldmacher has received research support from Biogen. The institution of Dr. Geldmacher has received research support from Eisai. The institution of Dr. Geldmacher has received research support from Janssen. The institution of Dr. Geldmacher has received research support from National Institutes of Health. The institution of Dr. Geldmacher has received research support from Vaccinex. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a CME presenter with Medscape. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a CME presenter with Med Learning Group. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生.
Brandalyn Riedel, MSG (University of Southern California) No disclosure on file
No disclosure on file
Vladimir S. Kostic, MD, PhD (Institute of Neurology CCS) Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of 好色先生, Science and Technological Development of Serbia.